Viatris, Inc. (VTRS)
16.54
+0.22
(+1.38%)
USD |
NASDAQ |
Aug 24, 16:00
16.54
0.00 (0.00%)
After-Hours: 20:00
Viatris Total Assets (Quarterly) : 35.04B for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 35.04B |
| March 31, 2026 | 36.83B |
| December 31, 2025 | 37.19B |
| September 30, 2025 | 37.92B |
| June 30, 2025 | 38.41B |
| March 31, 2025 | 38.47B |
| December 31, 2024 | 41.50B |
| September 30, 2024 | 44.75B |
| June 30, 2024 | 45.33B |
| March 31, 2024 | 47.34B |
| December 31, 2023 | 47.69B |
| September 30, 2023 | 48.74B |
| June 30, 2023 | 48.70B |
| March 31, 2023 | 49.29B |
| December 31, 2022 | 50.02B |
| September 30, 2022 | 48.66B |
| June 30, 2022 | 51.13B |
| March 31, 2022 | 53.47B |
| December 31, 2021 | 54.84B |
| September 30, 2021 | 56.07B |
| June 30, 2021 | 57.98B |
| March 31, 2021 | 58.98B |
| December 31, 2020 | 61.55B |
| September 30, 2020 | 31.24B |
| June 30, 2020 | 30.16B |
| Date | Value |
|---|---|
| March 31, 2020 | 30.15B |
| December 31, 2019 | 31.26B |
| September 30, 2019 | 31.05B |
| June 30, 2019 | 31.82B |
| March 31, 2019 | 31.91B |
| December 31, 2018 | 32.73B |
| September 30, 2018 | 33.46B |
| June 30, 2018 | 33.27B |
| March 31, 2018 | 35.18B |
| December 31, 2017 | 35.81B |
| September 30, 2017 | 35.82B |
| June 30, 2017 | 35.51B |
| March 31, 2017 | 34.27B |
| December 31, 2016 | 34.73B |
| September 30, 2016 | 36.54B |
| June 30, 2016 | 28.84B |
| March 31, 2016 | 22.64B |
| December 31, 2015 | 22.27B |
| September 30, 2015 | 21.32B |
| June 30, 2015 | 22.79B |
| March 31, 2015 | 22.12B |
| December 31, 2014 | 15.89B |
| September 30, 2014 | 15.17B |
| June 30, 2014 | 15.60B |
| March 31, 2014 | 15.36B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Pfizer Inc. | 201.13B |
| Eli Lilly & Co. | 142.28B |
| Merck & Co., Inc. | 129.80B |
| Bristol Myers Squibb Co. | 87.63B |
| Johnson & Johnson | 201.06B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 20.78B |
| Shareholders Equity (Quarterly) | 14.26B |
| Debt to Equity Ratio | 0.9555 |
| Current Ratio | 1.488 |
| Net Debt Paydown Yield | 0.92% |